Clinical Trials
42 trialsClinical and Molecular Characteristics of Primary Aldosteronism in Blacks
National Institutes of Health Clinical Center (CC)
CAPTAIN-T2D
Sparrow Pharmaceuticals
ADERADHTA
University Hospital, Toulouse
Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome
Corcept Therapeutics
IMPACT-MACS
University of Texas Southwestern Medical Center
Isturisa Treatment in Mild Autonomous Cortisol Secretion( MACS)
Johns Hopkins University
Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS)
Mayo Clinic
LINC CARE
RECORDATI GROUP
RESCUE
Sparrow Pharmaceuticals
Metyrapone for Mild Autonomous Cortisol Secretion (MACS)
Mayo Clinic
GRADIENT
Corcept Therapeutics
Metyrapone Study for Patients Diagnosed With Mild Autonomous Cortisol Secretion - MACS
Mayo Clinic
GRACE
Corcept Therapeutics
A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome
Crinetics Pharmaceuticals Inc.
Effects of "Vitamin N" Nature Immersion Therapy on Stress Levels in Health Care Workers in the City of Bogotá
Instituto Nacional de Salud, Colombia
3DAdrenal
University of Palermo
CODE:QoL
University of Zurich
SuddenDeath
Helsinki University Central Hospital
PATHOS
Istituto Auxologico Italiano
Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)
Corcept Therapeutics
CXCR4 Targeted PET Imaging in APA Preoperative Localization Diagnosis
Zhongnan Hospital
OSTCOR
Istituto Auxologico Italiano
An Exploratory Investigation of a Supplement to Promote Cognitive Health Benefits
Heights
Effect of Maternal Odor and Kangaroo Care on Serum Cortisol and Comfort Levels in Preterm Infants: a Randomised Trial
Istanbul Nisantasi University
First-in-human Evaluation of [18F]CETO
Uppsala University
CASE
Shanghai Jiao Tong University School of Medicine
Morbidity and Mortality in Autonomous Cortisol Secretion
Region Skane
Nailfold Capillaroscopy Evaluation in Cushing Syndrome Patients
Marmara University
Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome
Novartis
A Prospective Cohort Study for Patients With Adrenal Diseases
Seoul National University Hospital
Study to Evaluate CORT125134 in Participants With Cushing's Syndrome
Corcept Therapeutics
Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
HRA Pharma
Laparoscopic Adrenalectomy for Large Adrenal Tumors.
Samsun Liv Hospital
Salivary Cortisol as Stress Marker in Newborns Subjected to Double Weighing With Physiological Body Weight
Fondazione Poliambulanza Istituto Ospedaliero
SOM230 Ectopic ACTH-producing Tumors
Cedars-Sinai Medical Center
Saliva Cortisol Measurement as a Screening Test for Suspicious Cushings Syndrome in Children.
Haukeland University Hospital
Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
Novartis
A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia
Corcept Therapeutics
ISIRA
Charles University, Czech Republic
An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome
Corcept Therapeutics
Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome
Corcept Therapeutics
SEISMIC
Corcept Therapeutics